Savings Cards
Take It In
An oral (taken by mouth) medication, like ORACEA® (OR-AY-SHA) (doxycycline, USP) Capsule, works from the inside of the body to reduce the inflammatory lesions you see developing on the surface of your skin.
Take It Easy
With its once-daily dosing, ORACEA® may fit more conveniently into your busy schedule, but speak to your doctor about the right therapy option for you.
Topical Therapy

There are creams, lotions and gels available that treat the inflammatory lesions of rosacea directly on the surface of the skin.

Interested in a topical treatment option?

Ask your doctor about MetroGel® (metronidazole) Gel, 1%- the #1 prescribed topical therapy for the treatment of inflammatory lesions of rosacea.

LEARN MORE

In addition to treatment, you may improve your experience by avoiding triggers and practicing gentle skin care.

*For insured patients only. Certain limitations apply. Click here for program details.
Important Safety Information: ORACEA®
ORACEA® is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. You may experience intestinal upsets, sore throat or sinus infections/sinusitis when taking ORACEA®. Do not take ORACEA® if you are allergic to tetracyclines, and it may cause harm to a developing fetus; so do not take ORACEA® if you are pregnant or breastfeeding. When taking ORACEA®, stay out of direct or artificial sunlight, and make sure you tell your doctor if you have stomach or GI problems, kidney disease, have a yeast or fungal infection, take blood thinners, take oral contraceptives, or take medicine to treat acne, psoriasis or seizures. ORACEA® does not treat bacterial infections. Use ORACEA® only as prescribed by your doctor. For more information about ORACEA®, see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call
1-800-FDA-1088.


Important Safety Information: MetroGel® 1%
MetroGel® (metronidazole) Gel, 1% is indicated for the topical treatment of inflammatory lesions of rosacea. The following adverse events have been reported with the topical use of MetroGel® 1%: sore throat/nasal congestion, upper respiratory tract infections, headaches, burning, skin irritation, dryness and transient redness. There have also been reports of metallic taste, tingling or numbness of extremities and nausea with use of MetroGel® 1%, so tell your doctor if you experience these symptoms. Also, tell your doctor if you are using blood thinning drugs like coumarin or warfarin, because there is a risk of interaction with metronidazole. Do not use MetroGel® 1% if you are allergic to metronidazole or any of the other ingredients in the gel. For more information about MetroGel® 1%, see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call
1-800-FDA-1088.